Replies to post #513 on MultiCell Technologies Inc (MCET)

[tradenride]

Maybe the Sybiol Patent but they sold off their cell line to Corning. That just leave this MS treatment which was the former CEO's baby. With Chang gone, no financing and competition the likes of Biogen and Elan, MCET needs to reinvent themselves. I said long ago they needed to explore Nano. JMO